LONG-TERM SAFETY OF SIROLIMUS IN LIVER TRANSPLANT RECIPIENTS

被引：0
|
作者：
Ashraf, Taha [1 ]
Siddiqui, Mohammad B. [2 ]
Khorfan, Kamal [1 ]
Moonka, Dilip [2 ]
机构：
[1] Henry Ford Hosp, Internal Med, Detroit, MI 48202 USA
[2] Henry Ford Hosp, Gastroenterol, Detroit, MI 48202 USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1373
引用
收藏
页码：823A / 824A
页数：2
相关论文
共 50 条
  • [1] Long-Term Safety of Sirolimus in Liver Transplant Recipients
    Siddiqui, Mohammad
    Ashraf, Taha
    Khorfan, Kamal
    Latack, Katie
    Moonka, Dilip
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S513 - S514
  • [2] Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients
    Asleh, Rabea
    Briasoulis, Alexandros
    Kremers, Walter K.
    Adigun, Rosalyn
    Boilson, Barry A.
    Pereira, Naveen L.
    Edwards, Brooks S.
    Clavell, Alfredo L.
    Schirger, John A.
    Rodeheffer, Richard J.
    Frantz, Robert P.
    Joyce, Lyle D.
    Maltais, Simon
    Stulak, John M.
    Daly, Richard C.
    Tilford, Jonella
    Choi, Woong-Gil
    Lerman, Amir
    Kushwaha, Sudhir S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (06) : 636 - 650
  • [3] Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
    Yu, Ji Hyun
    Kim, Kyoung Woon
    Kim, Bo-Mi
    Chung, Byung Ha
    Cho, Mi-La
    Choi, Bum Soon
    Park, Cheol Whee
    Kim, Yong-Soo
    Yang, Chul Woo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (03): : 552 - 559
  • [4] Impact of the Conversion of the Immunosuppressive Regimen from Prograf to Advagraf or to Sirolimus in Long-term Stable Liver Transplant Recipients: Indications, Safety, and Outcome
    Perrakis, A.
    Schwarz, K.
    Yedibela, S.
    Croner, R. S.
    Hohenberger, W.
    Mueller, V.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (10) : 3702 - 3707
  • [5] Long-term transplant survival for liver recipients in the UK
    Barber, KM
    Hamilton, CJ
    Collett, D
    Mayer, D
    [J]. LIVER TRANSPLANTATION, 2004, 10 (06) : C34 - C34
  • [6] Steroid withdrawal in long-term liver transplant recipients
    Sterneck, M
    Fischer, L
    Weise, C
    Broering, D
    Rogiers, X
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3265 - 3267
  • [7] Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients
    Grant, D
    Rochon, J
    Levy, G
    Cattral, M
    Cheung, S
    Grieg, P
    Altraif, I
    Rezieg, M
    Wong, PY
    Adams, P
    Asfar, S
    Freeman, D
    Ghent, C
    Wall, W
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2232 - 2233
  • [8] Conversion From Sirolimus to Everolimus in Long-Term Liver Graft Recipients
    Weiler, Nina
    Bilge, Nigar
    Troetschler, Sven
    Vermehren, Johannes
    Schnitzbauer, Andreas Anton
    Herrmann, Eva
    Sarrazin, Christoph
    Zeuzem, Stefan
    Welker, Martin-Walter
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (07): : 837 - 845
  • [9] Addition of sirolimus to cyclosporine in long-term kidney transplant recipients to withdraw steroid
    Citterio, F
    Sparacino, V
    Altieri, P
    Rigotti, P
    Calabrese, S
    Poli, M
    Vinti, V
    Segoloni, GP
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 827 - 829
  • [10] Long-term Outcome of Conversion to Sirolimus Monotherapy After Liver Transplant
    Uhlmann, Dirk
    Weber, Tonja
    Ludwig, Stefan
    Ludwig, Barbara
    Bartels, Michael
    Hauss, Johann
    Jonas, Sven
    Witzigmann, Helmut
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2012, 10 (01) : 30 - 38
12345